AMP Commends Congress for Nixing VALID Act
The Association of Medical Pathology (AMP) applauded Congress for not including the VALID Act in the Consolidated Appropriations Act of 2023.
Read MorePosted by Chris Wolski | Dec 26, 2022 | Compliance, Miscellaneous |
The Association of Medical Pathology (AMP) applauded Congress for not including the VALID Act in the Consolidated Appropriations Act of 2023.
Read MorePosted by Chris Wolski | Dec 23, 2022 | Calibrators |
Verichem Laboratories now offers ready-to-use, liquid stable clinical reference materials for Total Cholesterol, HDL, and LDL testing.
Read MorePosted by Andy Lundin | Dec 15, 2022 | Prostate |
Researchers pioneered and implemented a novel algorithm to provide genetic testing to patients with newly diagnosed prostate cancer.
Read MorePosted by Andy Lundin | Dec 13, 2022 | Compliance |
The AACC is urging clinical lab professionals to write to their legislators to keep the VALID Act out of a Fiscal Year 2023 budget agreement.
Read MorePosted by Andy Lundin | Dec 7, 2022 | Compliance |
AMP is urging medical organizations to contact their elected officials to remove the VALID Act from a 2023 “omnibus” appropriations bill.
Read More